Adenocarcinoma of esophagogastric junction
Clinical trials for Adenocarcinoma of esophagogastric junction explained in plain language.
Never miss a new study
Get alerted when new Adenocarcinoma of esophagogastric junction trials appear
Sign up with your email to follow new studies for Adenocarcinoma of esophagogastric junction, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Immunotherapy boosts chemo before stomach cancer surgery in new trial
Disease control OngoingThis phase 2 trial tests whether adding the immunotherapy drug serplulimab to standard chemotherapy before surgery helps patients with advanced stomach or gastroesophageal junction cancer. About 116 participants will receive either the combo or chemo alone for three cycles before…
Matched conditions: ADENOCARCINOMA OF ESOPHAGOGASTRIC JUNCTION
Phase 2 • Sponsor: Xijing Hospital • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
Triple attack on HER2-Positive stomach cancer: can chemo, targeted therapy and immunotherapy shrink tumors before surgery?
Disease control OngoingResearchers are testing whether combining FLOT chemotherapy, trastuzumab and toripalimab before and after surgery helps people with HER2-positive stomach or esophagogastric junction cancer. The trial enrolls about 30 adults with locally advanced, operable tumors. Participants rec…
Matched conditions: ADENOCARCINOMA OF ESOPHAGOGASTRIC JUNCTION
Phase 2 • Sponsor: Yu jiren • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC